The plant family Amaryllidaceae is renowned for its unique alkaloid constituents which possess a significant array of structural diversity. Several of these alkaloids are known for their interesting biological properties, of which galanthamine and pancratistatin have acquired a privileged status due to their relevance in the pharmaceutical arena. In particular, galanthamine represents the first prescription drug emanating from the Amaryllidaceae after its approval by the FDA in 2001 for the treatment of Alzheimer's disease. Following on this commercial success there have been sustained projections for the emergence of an anticancer agent related to pancratistatin due to the potency, selectivity, low toxicity and high tolerability typifying targets of this series of alkaloids. The lycorine series of alkaloids have also garnered widespread interest as cytotoxic agents and were amongst the earliest of the Amaryllidaceae constituents to exhibit such activity. To date over 100 of such naturally-occurring or synthetically-derived alkaloids have been screened for cytotoxic effects against a number of cancer cell lines. This survey examines the cytotoxic properties of lycorine alkaloids, highlights the outcomes of structure-activity relationship orientated studies and affords plausible insights to the mechanistic rationale behind these effects.
Given the vast global natural biodiversity the plant kingdom, comprising around 500,000 higher plant species, affords an unlimited resource platform for drug discovery [1] . The potential for further discoveries being made from this floral abundance is at a premium considering that less than 20% of known plants have been subjected to studies for therapeutic effects [2] . It has been estimated that more than 3000 plant taxa have been described worldwide with evidence in the treatment of cancer [3] . Considering these statistics, it is understandable that between the years 1981-2006 over 47% of 155 clinically-approved anticancer drugs were natural productderived chemotypes [4] . Featuring prominently in this list are the vinca alkaloids (vinblastine, vincristine, vinorelbine), the epipodophyllotoxin lignans (etoposide, teniposide, etoposide phosphate), the taxane diterpenoids (paclitaxel, docetaxel) and the camptothecin quinoline alkaloid derivatives (toptotecan, irinotecan) [3] .
From of old, plants of the family Amaryllidaceae have been used in the traditional medicine of indigenous peoples across the globe [5] . Furthermore, several of its members have been indicated for the treatment of cancer in the ethnic medicine of the various regions of prominence of this plant family, including Andean South America, the Mediterranean and Southern Africa [6] . Guided in part by such indigenous knowledge systems, the search for the chemical entities responsible for these and other biological effects has garnered widespread attention [5] . Such endeavours have also uncovered the wide array of structural diversity innate to this plant family, especially its unique alkaloid constitution [5] . In this regard, lycorine (1), crinine (2) and galanthamine (3) (Scheme 1) are representative of the three major classes of alkaloids produced by members of the Amaryllidaceae, with a further three minor group representatives also occurring in many species [5] . Of these, galanthamine is best known in both the scientific and secular literature due to its commercial success as an Alzheimer's prescription drug [7] . The crinane group, as exemplified by crinine (2) , is known for a wide range of biological properties of which its cytotoxic effects have been most studied [8] .
The lycorine group is a large and expanding set of Amaryllidaceae alkaloids containing close to 200 structural varieties which also possess a diverse array of biological activities [5] . Its chief representative, lycorine (1) , was the first alkaloid described from the Amaryllidaceae and is now the most common constituent found across most genera of the family [5] . Structurally, lycorine alkaloids are comprised of a basic phenanthridine nucleus making up rings A,B and C with varying degrees of oxygenation in each of the rings [5] . The diagnostic feature of their structural makeup is the presence of the ethyl tether adjoining C-4 and the N-atom to form the 1,2,3trisubstituted pyrrole D-ring [5] . A methylenedioxy moiety straddling C-8 and C-9 is common, while a C-6 keto group is present in a few analogues and the 1,2-trans-substituted dihydroxy groups of ring-C is a striking feature of lycorine alkaloids [5] . In addition, rings B and C are trans-fused and the double bond is usually situated at the C,D-ring junction [5] .
Included amongst the various biological effects manifested by lycorine and its congeners are: antiviral, antibacterial, antifungal, antiplasmodial, anti-oxidant, anti-inflammatory and insect antifeedant effects, as well as acetylcholinesterase (AChE), ascorbic acid biosynthesis and RNA inhibitory activities [9] . The cytotoxic potential of lycorine alkaloids has been gaining impetus over the past three decades and can be linked directly to the considerable success experienced in the cancer arena by the phenanthridone representatives of the group, such as pancratistatin (4) and narciclasine (5) [6b,10]. As a distinct niche within the lycorine group these alkaloids have been shown to be potent and cell linespecific antiproliferative agents from which an anticancer drug target is projected for development within the next decade [6b,10]. Structurally, these phenanthridones are remininscent of lycorine alkaloids in featuring oxygenated A-and C-ring functionalities, but in which the pyrrole moiety is lacking [5] . A key feature in the cytotoxic propensity of such phenanthridones is the ability to induce apoptosis selectively in cancer cells with minimal effect on normal cells [10] .
Given the substantial growth of research examining the cytotoxic potential of lycorine alkaloids [8, 9, 10] , as a consolidation of these efforts we here cover this aspect of their multifarious biological characteristics by addressing three areas selected as the theme for this review. These include; 1) cytotoxic activities of lycorine alkaloids in various cancer cells; 2) effects of structure on cytotoxic activity; and 3) the mechanisms behind the cytotoxic activities.
As early as 1952, Yamaguchi and Suda reported the germination and growth inhibitory effects of lycorine (1) in Vicia faba L. at a concentration of 10 -2 M, showing in the process that these effects were related to several cytological changes, including inhibition of the metaphasic stage and chromosomal aberration [11a] . The conclusion from these findings was that the physiological effects of lycorine are mediated through its action on cell division [11a] . Further studies into these effects showed that even at lower concentrations (10 -4 to 10 -6 M), lycorine inhibited cell division in explants of lettuce pith parenchyma and liquid yeast cultures [11b] . Interestingly, De Leo et al. (1973) revealed that there was a notable decrease in 3 H-uridine and 14 C-leucine incorporated into RNA and protein, respectively, in lycorine-treated pea internodes [11c] . The search for the chemical entities responsible for these effects showed that of the lycorine series, lycorine (1) and pseudolycorine (6) (Scheme 1) were capable of inhibiting the peptide bond formation step of protein synthesis catalysed by eukaryotic ribosomes [11d]. However, it was also shown that these two alkaloids had a different binding site on the peptidyl transferase centre of the 60S ribosomal unit shared by other Amaryllidaceae alkaloids such as haemanthamine, pretazettine and narciclasine [11d]. These interesting observations made for lycorine with plant media consequently directed efforts towards animal models of study, which have subsequently come to dominate the field. Interest in the cytotoxic potential of lycorine alkaloids was also stimulated by the findings of Ceriotti in 1967 which revealed narciclasine (5) as a potent antimitotic substance with marked antitumor effects [12] .
Furusawa and co-workers 1971 initially showed that an alkaloid, thought to be pseudolycorine (6), was responsible for antiproliferative activity against Rauscher leukemia in BALB/c mice [13] . As such, the alkaloid at its maximum nontoxic dose (MNTD) of 10 mg/kg effected a 102% prolongation of lifespan in the mice when compared with vincristine (53% prolongation, MNTD 0.15 mg/kg) [13] . The first major advance in the field was that of Jimenez 
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Natural Product Communications Vol. 9 (8) 2014 1195 several Amaryllidaceae alkaloids on the inhibition of protein synthesis in eukaryotic cells [14] . In this study, minimum inhibitory concentrations (MICs) observed for lycorine (1) , pseudolycorine (6) and dihydrolycorine (7) against the HeLa cell line were 6, 25 and 100 M, respectively (Table 1 ) [14] . Norpluviine (8) was the only compound of the lycorine series shown to be void of activity in this screen [14] . The three alkaloids lycorine, pseudolycorine and dihydrolycorine were also capable of inhibiting DNA synthesis in Krebs II ascites cells, indicating a possible interaction between them and the DNA synthesizing system in mammalian cells [14] .
Next, Zee-Cheng and co-workers (1978) examined several ungeremine (9) analogs for activity against Rauscher leukemia (P388) in mice [15] . Out of these, ungeremine and its chloride salt (10) were noticeably active with a T/C index of 133% each at the lowest dosage of 3.13 mg/kg (where the minimum requirement for activity was set at T/C 125%) [15] . By contrast, compound 11 exhibited a T/C index of 127% (at 6.25 mg/kg) and compound 12 was conspicuous for its weak activity (T/C 118% at 50 mg/kg treatment) [15] . Following these observations, Furusawa et al. (1980) investigated twenty-four representatives of five different structural classes of Amaryllidaceae alkaloids for effects against Rauscher virus-carrying NIH/3T3 cells [16] . Minimum toxic doses (MTD) observed for lycorine (1), pseudolycorine (6) and ungeremine (9) were 0.2, 1 and 10 g/mL, respectively. Both lycorine and pseudolycorine had a selectivity index (SI) of 1, taking into consideration minimum antiviral dose (MAD) and MTD ratios, compared with the standard antileukemic drugs adriamycin (SI 50) and vincristine (SI 100) [16] .
Based on the good activity initially observed for various extracts of Amaryllis belladonna in the in vivo P-388 lymphocytic leukemia system (T/C index up to 203% at 50 mg/kg), Pettit and co-workers (1984) undertook a phytochemical investigation of the plant which led to the identification of two lycorine variants anhydrolycorinium chloride (11) and acetylcaranine (13) [17] . In vitro, both compounds were active against P-388 cells with ED 50 s of 1.4 and 0.23 g/mL, respectively. Furthermore, in the in vivo test against the same cells anhydrolycorinium chloride improved life extensions to 64-69% at dose levels of 10-20 mg/kg [17] . Following this, Ghosal et al. (1985a) reported that hippadine (14) potentiated the viability of S-180 tumor cells via membrane stabilization [18] . Based on these findings, Ghosal et al. (1985b) then examined several lycorine constituents of Crinum asiaticum against S-180 ascites tumor cells, showing that in vitro cell viabilities after treatment with lycorine (1) and compounds 15-17 were 63%, 69%, 98% and 96%, respectively (Table 1 ) at a test concentration of 1 M [19] . In relation to in vivo effects, lycorine effected the growth of the lowest number of ascites tumors in Swiss mice (7.25 x 10 7 cells) compared with the other three alkaloids, where the number of viable cells counted for 15-17 were 12.84 x 10 7 , 14.62 x 10 7 and 14.54 x 10 7 , respectively, at a treatment dose of 5 mg/100 g [19] . In addition to these studies, Ghosal et al. (1986) also described the presence of ungeremine (9) and criasbetaine (18) in mature fruits of Crinum asiaticum, the latter of which showed significant antitumor activity in the in vitro P388 (ED 50 0.82 g/mL) and KB (ED 50 1.2 g/mL) tests [20] . Further to these results, Ghosal et al. (1988) also reported that ungeremine (9) exhibited strong antitumor effects, reducing the viability of S-180 ascites tumors in vitro to 15% [21] . In vivo, there was a marked reduction in the growth of tumor cells in Swiss mice from 17 x 10 7 cells counted in the control to 8.2 x 10 6 cells upon treatment with ungeremine at the 5 mg/100 g dosage level [21] . Three years later, Abd El Hafiz et al. (1991) reported the presence of several alkaloids in Crinum augustum and C. bulbispermum, of which the lycorine variant pratorinine (19) was shown to be inactive in Molt-4 cells, as indicated via low [ 3 H]-thymidine incorporation ( Table 1 ) [22] .
Not long after this study, Likhitwitayawuid et al. (1993) isolated five alkaloids from bulbs of Crinum amabile collected in Bangkok, Thailand, which were subsequently screened for cytotoxic effects against twelve different cancer cell lines and antiplasmodial activity against both chloroquine-sensitive D-6 and chloroquine-resistant W-8 strains of Plasmodium falciparum [23] . In the bioassay, compared with the four -crinane alkaloids described, lycorine (1) was the most active compound with ED 50 s ranging from 0.3 g/mL (in KB cells) to 1.6 g/mL (observed for both BCA-1 and MEL-2 cells) [23] . However, the low selectivity index (SI) value of 1 determined for ED 50 ratios in KB cells and both malarial parasites indicated that the compound in this instance did not exhibit a greater predisposition for cytotoxicity [23] . This notwithstanding, these findings are significant in that they represent the first comprehensive study of the cytotoxic effects of lycorine. In a similar manner, Lin et al. (1993) [24] screened various alkaloid isolates from Hymenocallis littoralis for cytotoxic activity against the same cell lines described above [23] , showing that the ED 50 s for lycorine (1) in this screen were similar to those reported by Likhitwitayawuid and co-workers (1993) [23] . In addition, lycorine was also shown to be cytotoxic (ED 50 0.4 g/mL) to COL-2 human colon cancer [24] .
In continuation of studies involving the cytotoxic effects of Amaryllidaceae alkaloids, Weniger et al. (1995) examined 25 alkaloids belonging to different skeletal types for activity in the three cell-line screen involving Molt-4, LMTK and HepG2 cells [25] . Of the seven classes of alkaloids represented, the lycorine compounds were the most active across all three cell lines, with lycorine itself shown to be the pick of the library with ED 50 s of 0.4, 0.3 and 13 g/mL against the three cells, respectively [25] . Good activities were also observed for pseudolycorine (6) (ED 50 s 0.5, 0.4 and 10 g/mL) and 2-O-acetylpseudolycorine (20) (ED 50 s 0.6, 0.6 and 26 g/mL), whereas the activities for sternbergine (21) and galanthine (22) as shown in Table 1 were markedly lower [25] . Intriguingly, activities of the majority of alkaloids tested against HepG2 were moderate to mild (ED 50 s 9 to >50 g/mL) with only lycorenine (of the homolycorine series) exhibiting good activity (ED 50 1.2 g/mL) [25] . Not long after this, Duy and co-workers (1997) revealed that lycorine (1) was active in a three cell line screen involving HL-60S (adriamycin sensitive), HL-60R (adriamycin resistant) and L1210 cells in which cell viabilities were diminished in a dose-dependent manner, with 10-20% seen at the 5 g/mL dosage mark [26] . A search for antiproliferative agents from South African Amaryllidaceae plants led to the phytochemical investigation of Brunsvigia littoralis [27] .
In this investigation by Campbell et al. (1998) bulb extracts yielded four known alkaloids, including two lycorine variants lycorine (1) and 1,2-di-O-acetyllycorine (23) (Scheme 1), all of which were screened for cytotoxic effects against mouse melanoma (BL6) cells, as well as antimalarial activity against chloroquine-sensitive D-10 and chloroquine-resistant FAC-8 strains of Plasmodium falciparum [27] . IC 50 values obtained for lycorine and 1,2-di-O-acetyllycorine in the cytotoxicity assay were 1.8 and 8.9 g/mL, respectively ( Table 2 ) [27] . Selectivity was in favor of cytotoxicity as inferred from SI values which were shown to be 3 and 9 for lycorine and 1,2-di-O-acetyllycorine, respectively, when measured against IC 50 s for the D-10 and FAC-8 malarial pathogens [27] . Lycorine (1) isolated from Crinum delagoense was again shown by Nair et al. (1998) to be active against BL6 mouse melanoma cells [28] . In continuation of these efforts, Campbell and co-workers (2000) then examined another Brunsvigia species, in this case B. littoralis, for cytotoxic effects against the same cell line [29] . Of the two lycorine compounds identified, 1-O-acetylnorpluviine (24) and anhydrolycorin-6-one (25) were active in the BL6 assay with IC 50 values determined as 1.6 and 3.3 g/mL, respectively [29] .
Synthetic studies by Stark et al. (2000) directed towards lycorine variants of the Amaryllidaceae led to the targets ungeremine hydrochloride (10), criasbetaine (18) and tortuosine chloride (26) via a key-step Ziegler-Ullmann reaction [30] . All three compounds were subjected to the NCI 60 cell-line screen in which activities against the SF-268 CNS cancer ( Table 2 ) were most pronounced (GI 50 s of 0.912, 4.27 and 0.0174 M, respectively) [30] . It was also gauged from these studies that the high selectivity and efficacy of tortuosine chloride (26) against SF-268 cells compared favorably with maximum in vitro growth inhibition responses shown for ellipticinium and protoberberine-type CNS-selective antitumor agents used in practice for this cell-type [30] , making it a promising chemotherapeutic agent for development against human glioblastoma [30] . Barthelmes et al. (2001) then examined the effects of ungeremine (9) on various tumor cells using the sulforhodamide B assay, revealing that this betaine was potent against all five cell lines screened (IC 50 s 0.7 to 2.5 M) with the best activity seen in Molt-4 lymphoma cells (Table 1 ) [31] . In addition, this work also showed that subcutaneously implanted human gastric tumor (GXF251) xenografts in athymic nude mice were reduced significantly via twice-weekly intraperitoneal treatment with ungeremine over 4 weeks at 60 mg/kg [31] . In the same year, Min et al. (2001) isolated lycorine (1), pratorimine (27) and criasiaticidine A (28) (Scheme 1) from bulbs of the Japanese plant Crinum asiaticum and carried out a screen against two mouse tumor cells [32] . Of the three alkaloids, lycorine was shown to be the most active with ED 50 s of 0.3 and 0.5 g/mL against Meth-A sarcoma and LLC lung carcinoma cells, respectively [32] . ED 50 s for the other two alkaloids in both cell lines ranged from 3.2 to >10 g/mL [32] . In view of the strong antitumor activity measured in vitro for lycorine, Min et al. (2001) in the same investigation explored these effects in vivo using BDF-1 mice implanted subcutaneously with LLC cells [32] . The results showed that treatment with lycorine at 10 mg/kg/day over a 14-day period produced a notable decrease in tumor size (T/C index 80.5%) [32] .
Following these observations, Hohmann and co-workers (2002) carried out further studies on lycorine in mouse tumor cells using L5178 lymphoma as well as its multi-drug resistant form L5178mdr [33] . Of the nine alkaloids described from Sprekelia formosissima and Hymenocallis x festalis, lycorine was most apparent for strong activities against both of the above tumors with IC 50 s of 0.27 and 0.25 g/mL, respectively ( Table 2 ) [33] . Given the closeness of the results in both cell forms, lycorine was then tested for its ability to reverse multi-drug resistance in the mouse lymphoma L5178mdr cell line [33] . In this regard, at 1 g/mL lycorine displayed a low efflux pump inhibitory effect as indicated by a fluorescence activity ratio (R) of 0.53 compared with the standard verapamil (R = 2.68) and was, therefore, deemed an unlikely substrate for the glycoprotein responsible for the efflux pump activity of the tumor cells [33] . In addition, lycorine (1) exhibited low interaction with thymus DNA and Saccharomyces tRNA judging by the low temperature differential measured after decomplexation [33] . The following year, Phan et al. (2003) examined the two Asian species Crinum latifolium and C. asiaticum for cytotoxic effects and showed that of the lycorine constituents tested [lycorine (1), (30) ], only lycorine was active in the three cell line screen which included HepG2 (human hepatoma), FI (human cervical adenocarcinoma) and RD (human rhabdomyosarcoma) cells [34] . Liu and co-workers (2004) then examined the adverse effects of lycorine on human promyelocytic leukemia (HL- 60) , showing that the survival rate of cells exposed to lycorine decreased in a dose-dependent manner with 1M of the compound determined as the 50% inhibitory concentration [35] . Liu et al. (2007) extended their studies of HL-60 cells to include an in vivo mouse model using severe combined immuno-deficient (SCID) BALB/c mice [36] . To this extent, intravenous treatment of mice inoculated with HL-60 cells (5 x 10 6 ) with lycorine once a day up to 18 days at 5 or 10 mg/kg/day produced a decrease in the percentages of immature granular leukocytes and monocytes in the peripheral blood cells [36] . Furthermore, mean survival times for both lycorine-treated groups were longer than those of the control group and no adverse effects were observed in HL-60 inoculated mice upon administration of lycorine [36] . Li and co-workers (2007) then examined the effects of lycorine on the human multiple myeloma (KM3) cell line and showed via MTT assays that after 48 h it induced a dose-dependent decrease in the number of viable cells from 89% to 21% with an IC 50 of 1.25 M [37] . In comparison, the standard melphalan, which is used routinely in the treatment of multiple myeloma (MM), at concentrations of 1 to 16 M produced a decrease in survival rate from 84% to 10% with an half-effective concentration of 3.2 M indicating that these tumor cells were up to 2.5 times more sensitive to lycorine than the clinical drug [37] . (21), ungiminorine (32) and LT4 (33) (Scheme 1) [39] . Although no tests were carried out on cancer cells, the (3S)-hydroxybutyryl ester (33) was shown to be toxic to normal human fetal lung (MRC-5) fibroblast cells with an IC 50 of 8.11 g/mL [39] .
Gauging by the literature output, the period 2009-2013 saw significant growth in studies based on the cytotoxic potential of lycorine alkaloids. In 2009 alone, nine papers [10b-c, [40] [41] [42] [43] [44] [45] [46] addressed this theme characteristic of this group of alkaloids. Firstly, Liu and colleagues (2009) examined the effects of lycorine against five different human leukemia cell lines, including HL-60, K562, K562/G01, U937 and 6T-CEM cells which exhibited IC 50 s of 1, 1.7, 7, 1.9 and 2 M, respectively [40] . Interestingly, lycorine was indiscriminate between K562 human myelogenous leukemia and its imatinib-resistant form (K562/G01) as the alkaloid, as shown in Table 2 , inhibited the growth of both cells to a similar extent [40] . Other interesting results from this study centered on the mechanistic basis to these antiproliferative activities which will be considered elsewhere in the manuscript. Zupko et al. (2009) next studied the effects of 2-O-acetyllycorine (34) isolated from Leucojum vernum on the viability of five different human tumors, including HeLa, MCF-7, A-431, L5178 and L5178mdr cells [41] . As such, IC 50 s ranged from 10.3 to 19.8 M (Tables 1,2) with the best activity seen for HeLa cells [41] . However, these activities were on average about 100 times less than that observed for the doxorubicin positive control (for example, IC 50 against HeLa was 0.15 M) [41] . In addition, 2-O-acetyllycorine (34) was also tested for its ability to reverse multi-drug resistance in L5178mdr cells via the Rh-123 accumulation assay which is an indicator for Pgpmediated drug efflux inhibition, but exhibited significantly lower effects than the verapamil positive control [41] . Interestingly, it was shown via the MTT colorimetric assay that 2-O-acetyllycorine produced a synergistic effect when evaluated together with doxorubicin, with a fractional inhibitory index (FIX) value of 0.41 [41] .
The next piece of work in the field was that of Sun et al. (2009) covering the cytotoxic constituents of Crinum asiaticum L. var. sinicum Baker [42] . The ten alkaloids isolated from this plant, including six (1, 9, 14, 28, 35, 36) of the lycorine series, were screened for cytotoxic effects against A549, LOVO, 6T-CEM and HL-60 tumor cells [42] . Not surprisingly, lycorine (1) was the most active of this set of alkaloids with IC 50 s of 0.65, 0.59, 1.42 and 0.17 g/mL against the four cell-lines, respectively [42] . Ungeremine (9) exhibited potent activities against A549 (IC 50 0.43 g/mL) and HL-60 (IC 50 0.63 g/mL) cells, although its response to LOVO (IC 50 13.1 g/mL) and 6T-CEM (IC 50 3.89 g/mL) was moderated [42] . Activities for criasiaticidine A (28) and the D-seco-lycorine variant (36) were moderate to mild with IC 50 s ranging from 11.7 to 40 g/mL [42] . The lycorine variant (35) , possessing an unusual 1,2-morpholine D-ring, and hippadine (14) were unresponsive (IC 50 s > 100 g/mL) against all four cell lines [42] . Given the renowned antiviral properties of lycorine [8a] , Zhou et al. (2009) examined the effects of this compound on monkey kidney epithelial (Vero) cells infected with an epidemic strain of West Nile virus [43] . The results showed that lycorine suppressed viral titer in a dose-responsive manner with a 900-fold reduction observed at 1.2 M [43] . In order to exclude the possibility that antiviral activity was due to compound-mediated cytotoxicity, the effect of lycorine was tested separately on uninfected Vero cells via the MTT assay which showed that the 50% cytotoxic concentration (CC 50 ) was at 24 M [43] . Furthermore, a 1.5 M dose of lycorine restored cell viability to the 90% mark thus allowing for subsequent experiments to be conducted at this concentration [43] . leukemia (Jurkat) cell line, of which lycorine (1) and pseudolycorine (6) (Scheme 1) were noticeably active [44] . At a dosage of 10 M over 72 h, both compounds were able to induce apoptosis in Jurkat cells up to 87% and 86%, respectively ( Figure 1 ) [44] . This study also allowed for silylative chemo-regioselective differentiation (Scheme 2) of the 1,2-dihydroxy groups in lycorine leading to 1,2-di-O,O-acetyllycorine (23) and 1-O-acetyllycorine (29) [44] . Together with the two silylated lycorine analogues (42 and 43) generated through this synthetic sequence, only 1-Oacetyllycorine (29) was capable of apoptotic effects greater than 40% in Jurkat cells at 10 M [44] . Cells undergoing apoptosis after treatment with either lycorine or pseudolycorine were shown to be brighter and more fragmented than normal untreated cells through the application of Hoechst staining techniques ( Figure 2 ) [44] .
Subsequently, Jitsuno and co-workers (2009) examined the South American Amaryllidaceae plant Habranthus brachyandrus for alkaloid constituents leading to the isolation of six known alkaloids, including the lycorine variants galanthine (22) and 9-Odemethylgalanthine (44) [45] . Both compounds were inactive against the human squamous carcinoma (HSC-2) cell line and exhibited low activity (IC 50 > 55 M) against HL-60 (human promyelocytic leukemia) cells ( Table 2 ) [45] . These responses are in stark contrast to that observed for pancratistatin (4), also identified during the course of the investigation, which was potently active against both HL-60 (IC 50 0.16 M) and HSC-2 (IC 50 1.1 M) cells [45] .
The final piece of work for the year 2009 was that of Lamoral-Theys and co-workers who made a comprehensive study of twentytwo structurally diverse lycorine alkaloids, including compounds 45-54) (Scheme 3), against six cancer and three normal cell lines [46] . Of note were the activities of lycorine (1) in the screen against A549, OE21, Hs683, U373, SKMEL and B16F10 cells with IC 50 s ranging from 4.3 to 8.5 M (Tables 2,3) [46] . Similarly, pseudolycorine (6), amarbellisine (41), lycorine chlorohydrin (46), 1,2--epoxylycorine (51) and lycorine hydrochloride (52) were strongly active with IC 50 s in the range 2 to 10 M, whereas the remaining compounds of the library exhibited cytotoxic index values greater than 10 M [46] . Of considerable interest to the therapeutic potential of lycorine compounds was the responsiveness of the above six alkaloids to four of the cell lines (A549, OE21, U373 and SKMEL) which are intrinsically resistant to proapoptotic stimuli [46] . Furthermore, in vivo antitumor assays showed that lycorine (1) improved the survival of B6D2F1 mice which had been orthotopically grafted with B16F10 melanoma cells when administered intravenous 40 mg/kg doses three times per week [46] . The administered active dose of 40 mg/kg was significantly lower than the maximum tolerated dose (>80 mg/kg) [46] .
These measurements were made in comparison with the reference drug cisplatin, which failed to provide significant therapeutic benefits under similar conditions [46] . In relation to cytotoxic effects against normal cells, only two compounds (51 and 54) exhibited IC 50 s that were less than 30 M against W138, WS1 and NHDF cells [46] . In this regard, lycorine displayed the highest potential therapeutic ratio in vitro, being at least 15 times more active against cancer than normal cells [46] . (53)] in the six cell line screen against A549, OE21, Hs683, U373, SKMEL and B16F10 cells, as previously described [46] . In addition, activity data was provided for galanthine (22) against all of the above six cell lines, which were shown to be moderate as IC 50 s in each case were greater than 10 M [48] .
Following these findings, Osorio et al. (2010) described the presence of the three lycorine alkaloids pseudolycorine (6), ungeremine (9) and zefbetaine (61) in the Colombian Amaryllidaceae plant Phaedranassa dubia [49] . Against normal mouse myoblast (L6) cells, ungeremine exhibited weak activity (IC 50 65.3 M) while pseudolycorine and zefbetaine were shown to be inactive up to 300 M ( [50] . This study also confirmed the activity of lycorine against SKMEL and B16F10 cells, as previously described [46] .
Feng and co-workers were the first for the year 2011 to investigate the cytotoxic effects of lycorine together with other alkaloid constituents isolated from Lycoris radiata [51] . Surprisingly, lycorine (1) . This was especially true for the last two cell lines against which lycorine (1) was previously shown to be strongly active (IC 50 s of 0.17 and 0.65 g/ml, respectively) [35, 42] . Further phytochemical studies on Lycoris species by Jitsuno et al. (2011) , in this case L. albiflora, led to the identification of several alkaloids [52] . All of the isolates were evaluated for cytotoxic effects against HL-60 myeloid leukemia and HSC-2 squamous carcinoma cells, of which lycorine (1) was conspicuous for strong activity against both of these human cell lines [52] . To this extent, IC 50 values were determined to be 1.1 and 5.1 M against these cancer cells respectively ( Table 2) [54] . To this extent, it was shown that lycorine (1) inhibited EV71 infection of RD cells in a dose-dependent manner with an IC 50 of 0.48 g/mL [54] . Furthermore, the cytotoxic concentration (CC 50 ) of lycorine on RD cells was determined to be 48.5 g/mL, 100 times that of its IC 50 against EV71 shown above ( Table 2 ) [54] . In addition, in vivo experiments were instructive and showed that at doses of 0.4 to 1.0 mg/kg, lycorine increased the survival of ICR mice lethally infected with EV71 to around 45% [54] . The investigation of Evdokimov et al. (2011) was the first to examine comprehensively the various structural elements of the lycorine pharmacophore responsible for its cytotoxic effects [55] . To this end, a library of thirty-two analogues (14,15,25,29,37,60,63-88) (Schemes 1,3) , all of which were semi-synthetically derived from lycorine (1), were screened against glioma (Hs683, T98G, U373), carcinoma (A549, PC3, MCF-7) and melanoma (SKMEL-28, B16) cells [55] .
Out of these, the parent compound was active across all eight cell lines screened with IC 50 s ranging from 0.9 M (in Hs683 and A549 cells) to 4 M (in PC3, MCF-7, SKMEL-28 cells) (Tables 1,2,3) [55]. However, the pick of the library was the bis-allyl derivative (86) with activities up to 6 M in SKMEL-28 cells and as low as 0.03 M in U373 cells [55] . Since none of the alkaloids exhibited discriminatory activity between cells either resistant (U373, T98G, A549, SKMEL-28) or sensitive (Hs683, B16F10) to apoptosis, it could be construed that they are able to overcome the intrinsic resistance of cancer cells to pro-apoptotic stimuli [55] . Kang and co-workers (2012) explored several facets of the mechanistic basis to the cytotoxicity of lycorine, in the process showing that the alkaloid exhibited negligible effects against mouse leukemic RAW264.7 monocytes [56] .
Phytochemical investigation of whole plants of Zephyranthes candida by Luo et al. (2012) led to the isolation of fifteen alkaloid structures which were then all screened for cytotoxic effects against five different cancer cells, including HL-60, K562, A-549, HepG2 and HT-29 cells (Tables 1,2,3) [57] . As such, good activities were observed for lycorine (1) across all cells with IC 50 s ranging from 1.6 M (in HL-60 cells) to 3.7 M (in HepG2 cells) [57] . However, these promising results were blighted by the fact that lycorine also exhibited significant activity against non-cancerous human Beas-2B bronchial epithelial cells (IC 50 4.9 M) [57] . A mechanistic study of the cytotoxic effects of lycorine in human K562 myelogenous leukemia cells revealed that this alkaloid, when examined at various concentrations over 48 h produced the best effects employing a 5 M solution at which point cell viability was diminished to 42% [58] . A study by He et al. (2012) on the effects of lycorine on normal canine kidney MDCK epithelial cells identified the cytotoxic concentration (CC 50 ) as 20.9 M [59]. This concentration value was necessary to support the antiviral study of lycorine (1) against various influenza virus strains which had been impregnated into MDCK cells [59] . In this regard, best activity for lycorine was seen against the H 5 N 1 GD178 strain (EC 50 < 0.46 M) [59] . [57] , lycorine here also exhibited significant activity (IC 50 1.9 M) against normal human fibroblast (BJ) cells [60] . For the year 2013, six papers appeared dealing with the cytotoxic properties of lycorine-related alkaloids [61] [62] [63] [64] [65] [66] . Firstly, Ma et al. (2013) examined the effect of various compounds on tumor cell growth and showed that lycorine (1), in a dose-dependent manner, significantly decreased cell viabilities of DLD-1 colorectal adenocarcinoma and murine N2A neuroblastoma cells [61] . A phytochemical investigation of Zephyranthes grandiflora by Katoch et al. (2013) led to the isolation of eight alkaloids, including the lycorine variants ungeremine (9), galanthine (22) , zephgrabetaine (89) and tortuosine (90), together with lycorine (1) (Schemes 1,3) [62] . All of these alkaloids were then subjected to a cytotoxicity screen using C-6 rat glioma and CHO-K1 Chinese hamster ovary cells which revealed lycorine as the most potent of the set with IC 50 values less than 10 g/mL against both cell lines (Table 4 ) [62] . Activities for the other lycorine variants ranged from 32.3 g/mL to >100 g/mL [62] . The ability of lycorine in this instance to target both normal and cancer cells again raises questions about its future development into a selective anticancer agent. Cao and co-workers (2013) then examined the potential of lycorine hydrochloride (52) (Scheme 1) as an anticancer agent against ovarian cancer [63] . Boosted by their initial findings, which revealed that lycorine hydrochloride inhibited mitotic proliferation of the highly invasive Hey 1B ovarian cancer cell line in a dose dependent manner (IC 50 1.2 M), these researchers ventured further to examine the in vivo toxic effects of this alkaloid [63] . As such, a xenograft model was applied to nude BALB/c mice subcutaneously injected with Hey 1B cells followed by daily intraperitoneal administrations of lycorine hydrochloride (52) at 15 mg/kg [63] . The results revealed that such treatments produced a pronounced decrease in tumor weight averages in test animals (103.2 mg) compared with untreated control subjects (271 mg) [63] . In addition, lycorine hydrochloride did not cause loss of body weight nor did it give rise to detrimental side effects in mice that received daily injections of the alkaloid [63] . In the same investigation, a further detailed study of thirty-nine other tumor cells showed that lycorine hydrochloride exhibited good activities, with IC 50 s < 10 M in thirty-seven of these cell lines with the best activity seen in U-87MG human brain star glioma cells (IC 50 In the screen against seven human tumors, lycorine (1) was shown to be the most active of the constituents with IC 50 s ranging from 9.4 M (in SHG-44 cells) to 11.6 M (in W480 cells) [64] . Cao and coworkers (2013) then investigated a further Asian Lycoris species, leading to the isolation of four alkaloids from L. caldwelli [65] . In this instance, 2-hydroxy-anhydrolycorine-N-oxide (91) (Scheme 3) was shown to be the most active of the compounds screened (IC 50 s 9.2 to 31.8 M) against eight different tumor cell lines [65] . Finally for this year, Nair et al. (2013) identified lycorine (1) as one of the eight alkaloid constituents of Boophone haemanthoides [66] . A subsequent screen involving three human cancer cell lines, including lymphoblastic leukemia (CEM), breast (MCF-7) and cervical adenocarcinoma (HeLa), showed lycorine to be potently active with IC 50 s of 1.8, 9.2 and 8.9 M, respectively [66] . However, these activities in the cancer cell lines were compromised by the fact that lycorine was also notably active against normal BJ fibroblasts (IC 50 [55] . The key steps in this operation included regio-chemoselective silylation or alkylation at the C-2 position of the parent compound, thus allowing for further elaboration at C-1 [67] . In this manner, thirty-five different analogs (92-126) (Schemes 4,5) were prepared and screened for cytotoxic effects against six cancer cells possessing varying degrees of apoptotic resistance, including carcinoma (A549, MCF7), glioma (T98G, Hs683) and melanoma (SKMEL-28, B16F10) cells (Tables  2,3 ). Overall, best activities were seen in A549 cells with IC 50 s ranging from 0.6 to 72 M [67] . Not surprisingly, the parent natural compound lycorine exhibited the most consistent activities with IC 50 s of 3.0, 10.9, 5.2, 2.1, 3.7 and 2.6 M across the above six cell lines, respectively [67] . Next, Wang and co-workers (2014) prepared sixteen analogs (23, 29, 46, 51, (127) (128) (129) (130) (131) (132) (133) (134) (135) (136) (137) (138) ) (Schemes 1,5) of lycorine and carried out a screen against seven different cancer cells [68] . The key step in this sequence of reactions was the acidcatalyzed regio-chemoselective cleavage of the C-2 acetate group from 1,2-di-O-acetyllycorine (23) leading to 1-O-acetyllycorine (29) , exploiting the greater reactivity of the allylic acetate group [68] . Although several of the semi-synthetic analogs exhibited activities across the cell lines screened, it was the parent compound lycorine which again excelled with IC 50 s ranging from 3.0 M (in HCT116 and SK-OV-3 cells) to 7.5 M (in K562 cells) (Table 4 ) [68] . The other alkaloid which stood out in activity was 1,2-epoxylycorine (51), as gathered from its IC  values which ranged from 2.7 M (in NCI-H460 and HL-60 cells) to 6.2 M (in A549 cells) [68] .
Tortuosine
Although this review has accounted for 134 different lycorine alkaloids which have been screened against over 100 cancer cell lines, less is known about the active pharmacophore and its attendant structural elements [10d,15] . Furthermore, to date, no information is available on the operable biochemical target. Nonetheless, it is clear from these studies that an intact pyrrolophenanthridine nucleus is essential for cytotoxic activity as truncated analogs were notably less active.
In relation to ring-A modification effects, a direct comparison could be made for lycorine (1) and pseudolycorine (6), which differ by virtue of their ring-A substituents, and the seventeen cell lines against which both have been screened (Tables 1,2,3 ). As such, lycorine was seen to be more active than pseudolycorine in the majority of assays carried out, and the three occasions that the latter was shown to be more active was in tests against normal (noncancerous) W138, WS1 and NHDF human fibroblasts [46] (Table  3) weaker in their cytotoxic effects than lycorine. These results thus highlight the importance of the ring-A methylenedioxy moiety to the integrity of the pharmacophore. Interestingly, no lycorine derivatives (natural or semi-synthetic) bearing substituents at either C-7 or C-10 have been subjected to cytotoxicity evaluation, although it could be argued from a synthetic standpoint that selective access to such ring-A analogs would be challenging.
In relation to ring-B effects, oxidation at the benzylic C-6 position to form an amide moiety has been explored for several lycorine analogs from which it can be construed that such an operation is detrimental to activity. For example, 6-oxolycorine (66) (Scheme 1) exhibited IC 50 s > 100 M in each of the five cell lines (Hs683, SKMEL28, B16F10, T98G, PC3) screened compared with lycorine whose activities in the same study ranged from 0.9 to 8.5 M (Table  3 ) [55] . A further option available for ring-B functionalization is quaternization of the nitrogen atom, which was also shown to have a negative effect as N-methyllycorine iodide (39) exhibited significantly lower activity in the nine cell lines against which it was screened together with lycorine (Tables 1,2,3) [10b,c,46]. By contrast, derivatization to the hydrochloride salt produced a markedly active compound (52) which has been screened against forty-four different cell lines in which IC 50 s were mostly < 5 M [46, 63] . Interestingly, lycorine hydrochloride (52) has been shown to be a selective cytotoxic agent as it exhibited negligible effects (IC 50 s > 100 M) in the three cell screen involving normal human fibroblast (W138, WS1 and NHDF) cells [46] . Thus, the introduction of charge to the molecule is apparently not deleterious in the case of hydrochloride salt formation, but it has a net negative impact via quaternary salt formation. Two examples (62 and 91) were found involving N-oxide bond formation whose effect has been shown to be negative [53, 65] .
A further manipulative step allows for ring-B iminium ion formation, but the outcome of this modification will be dealt with elsewhere in conjunction with aromatization effects.
The effects of ring-C modification may be gauged via functionalization at C-1, C-2, C-3 or C-4. It is clear that oxygenrelated substituents are required at both C-1 and C-2 for potent cytotoxic activity, highlighting the importance of hydrogen bond donor-acceptor functionalities at these positions. For example, lycorene (40), the 1,2-di-deoxy-analog of lycorine, exhibited low activities in all of the nine cell lines against which it has been screened together with lycorine [10b,c,46]. Furthermore, caranine (53), the 2-deoxy-analog of lycorine, also exhibited low activities in all six cell lines screened in conjunction with lycorine [46] . In general, acylation at C-1 or C-2 (or both) gave products which were less active than the parent alkaloid lycorine [55] . However, 1-Obenzoyllycorine (76) stands out for its potent activity (IC 50 0.6 M) in human U373 glioblastoma, making it a promising lead for chemotherapeutic development against such cancers [55] .
Similarly, alkylation at the C-1 or C-2 positions produced compounds with lower cytotoxic activities, but the 1,2-bisallyllycorine adduct (86) was also strikingly active (IC 50 0.03 M) against U373 cells (Table 1 ) [55] . The trend of the chlorohydrin (46) in the fifteen cell lines screened in parallel with lycorine (1) was towards lower reactivities, underlining the significance of oxygen-related substitution at the C-2 position [46, 68] . Stereochemical effects were significant as gauged through the relatively mild responses seen for 2-epi-lycorine (45) to six cancer cell lines wherein lycorine was also screened [46] .
Efforts to measure the effect of the double bond have been undertaken leading to the conclusion that this functionality is critical in the cytotoxic propensity of lycorine alkaloids [46] . In relation to this, both and -dihydrolycorine isomers (47 and 48) exhibited moderate activities (IC 50 s > 10 M) in each of six cell lines in which lycorine was also involved [46] . Shift of the double bond to either the 2,3-or 4,11-positions produced compounds (41, 71, 72) which were less reactive, as gauged by a screen involving fifteen cancer cell lines [10b,c, 46, 55] .
Finally, several lycorine analogs (both natural and synthetic) involving aromatization of ring-C were also examined for cytotoxic effects in cancer cells. For direct comparison, anhydrolycorine (54) was on average twice less-active than lycorine in each of the six cancer cells screened concurrently [46] . However, several other ring-C aromatized derivatives, such as ungeremine (9), ungeremine hydrochloride (10), criasbetaine (18) and tortuosine chloride (26) , were strongly active in several assays. In fact, the betaine ungeremine (9) , also in possession of a ring-B aromatic moiety via its iminium ion, is one of the most commonly studied cytotoxic (Tables 1-4 ). Its best activity is against human Molt4 T lymphoma wherein it displayed sub-micromolar activity (IC 50 0.7 M) [31] . Tortuosine chloride (26) is a noteworthy representative of the aromatized ring-C variants in that it is amongst the most active compounds identified within the lycorine series with a GI 50 of 0.0174 M in SF-268 human glioblastoma [30] .
Given that C-11 and C-12 are methylene carbon centers, little can be accomplished by way of synthetic manipulation to probe their cytotoxic influence. However, in cases where such a modification was present these analogs (14, 35, 36, 57 ) (Scheme 1) were several orders of magnitude less active than the parent lycorine, highlighting the relevance of an intact D-ring moiety to the active pharmacophore. However, the direct effect of this pyrrole ring on the antitumor activity of lycorine alkaloids is somewhat perplexing given that the most potent cytotoxic alkaloids of the Amaryllidaceae reside with the phenanathridones (such as pancratistatin (4) and narciclasine (5), which are devoid of this moiety.
Several suggestions have been made concerning the biological mechanisms behind the antitumor effects manifested by lycorine alkaloids. As mentioned above, early studies showed that the growth inhibitory effects of lycorine in some plant systems involved chromosomal aberration, including inhibition of the metaphasic stage [11a] , whilst in others there was evidence for the influence of amino acid incorporation into RNA and protein [11c] . Later studies by Hohmann et al. (2002) [33] revealed that the antiproliferative effect of lycorine resulted from its complex formation with RNA. Furthermore, lycorine (1) and pseudolycorine (6) were shown to inhibit the peptide bond formation step of protein synthesis catalyzed by eukaryotic ribosomes [11d]. The first mechanistic rationale to the cytotoxic effects of Amaryllidaceae alkaloids was that offered by Jimenez et al. (1976) who postulated that lycorine inhibited protein biosynthesis in tumor cells [14] . Evidence was also provided by the same authors to the extent that lycorine (1), pseudolycorine (6) and dihydrolycorine (7) were capable of interacting with DNA [14] . Studies carried out several years later by Liu et al. (2011) [54] revealed that lycorine reduced the cytopathic effect of enterovirus 71 (EV71) in RD cells by inhibiting replication via blockage of the elongation of the viral polyprotein during translation. Lycorine was also shown by Karadeniz et al. (2003) [69] to interact with calf thymus DNA in which case the voltammetric signals from guanine and adenine were markedly diminished. However, some experiments carried out by Vrijsen et al. (1986) [70] showed that lycorine is not an initiation inhibitor, whilst evidence from the findings of Kukhanova et al. (1983) [71] suggested that it could not inhibit the peptide bond formation step, but that it did in fact, under certain conditions, link to ribosomes. Papas et al. (1973) [72] had initially shown that the two lycorine variants lycorine (1) and pseudolycorine (6) were not active against DNA polymerase isolated from avian myeloblastosis virus. Another means by which lycorine could manifest its activity is via interference with cellular vitamin C biosynthesis, as pointed out by Arrigoni and co-workers in 1975 [73] .
Based on the strong inhibitory activities of Amaryllidaceae alkaloids, including the lycorine variants lycorine (1), pseudolycorine (6) and 2-O-acetylpseudolycorine (20) , against murine LMTK fibroblasts (Table 1) , Weniger et al. (1995) suggested that this could be due to the effect of the alkaloids on the protein of the cytoskeleton given that these are abundant in LMTK cells [25] . Recent findings by Liu et al. (2012) [74] on the effects of various inhibitors in the metastatic C8161 melanoma cell line revealed that lycorine hydrochloride (52) impeded VE-cadherin gene expression. From this result it was suggested that the inhibition might explain the reduced tumor angiogenesis and vasculogenic mimicry effects observed in the melanoma cells which are known to actively participate in both processes [74] . Furthermore, [63] showed that the antiproliferative effect of lycorine hydrochloride (52) on ovarian Hey 1B cancer was accompanied by enhancement of the cell cycle inhibitor p21 and marked downregulation of cyclin D3 expression. Lycorine hydrochloride also suppressed the expression of several key angiogenic genes, including VE-cadherin, vascular endothelial growth factor and Sema4D, in addition to reducing Akt phosphorylation [63] .
The inorganic free radical nitric oxide (NO) has been implicated in several physiological and pathological processes, including cancer, and is produced by oxidation of L-arginine by the enzyme NO synthase (NOS) [75] . The exact role of NOS in the pathophysiology of cancer is not clearly understood but it is known that high levels of NOS expression may be cytostatic or cytotoxic to tumor cells, whereas low level activity can have the opposite effect and promote tumor growth [75] . Lycorine has been shown to be effective at inhibiting iNOS (inducible nitric oxide synthase) in LPS-activated mouse peritoneal macrophages [76] . Furthermore, as described by Kang et al. (2012) , lycorine also inhibits LPS-induced iNOS and COX-2 up-regulation in RAW264.7 cells through the suppression of p38 and STATs activation [56] . LPS-induced tumor necrosis factor- (TNF-) is a major proinflammatory cytokine involved in the regulation of inflammation and related disorders [77] . Lycorine was shown to inhibit TNF- production in LPS-stimulated murine macrophages with an IC 50 value of 0.2 g/mL [77] . Furthermore, Liu et al. (2010) demonstrated that the TNF- signal transduction pathway and p21-mediated cell cycle inhibition were involved in the apoptosis of HL-60 cells induced by lycorine [78] .
A further area which has attracted significant interest in the mechanistic basis to the cytotoxic properties of lycorine alkaloids is their interaction with the topoisomerase enzymes, which perform important functions in the topology of DNA, especially in regulating its overwinding or underwinding [31, 79, 80] . In particular, the betaine ungeremine (9) has been shown to be a specific topoisomerase II inhibitor [31, 79, 80] . In human epidermoid A431 carcinoma cells, ungeremine induced immunoband-depletion of topoisomerase II suggesting it is capable of stabilizing the covalent catalytic DNA-intermediate in living cells [31] . Furthermore, evidence provided by Casu et al. (2011) [80] suggested that ungeremine impairs the activities of both human (I and II) and bacterial (IA and IV) topoisomerases. In addition to topoisomerase inhibition, some reports have pointed at the biochemical effect of the lycorine-calprotectin interaction as a significant marker in the mechanistic approach to its cytotoxicity [81, 82, 83] . Calprotectin is a calcium-binding protein complex found in polymorphonuclear leukocytes (PMNs) and has the capacity to induce growth inhibition and apoptotic cell death in a variety of tumor and normal cells [81, 82] . Initially, it was shown by Yui and co-workers (1998) that lycorine (1) not only inhibited cell death by calprotectin in mouse breast carcinoma MM46 cells [81] , but also inhibited the suppressive effect of calprotectin on target DNA synthesis at a half-effective concentration of 0.10.5 g/mL.
Of the various biochemical mechanisms invoked to explain the cytotoxic effects of lycorine alkaloids, it is their ability to induce apoptosis in tumor cells which has garnered the most interest. The findings of Yui et al. (1998) [81] was amongst the first to associate the adverse effects of lycorine on MM46 cells to the apoptotic mode Nair et al.
of death. Several years later, Liu et al. (2004) [35] presented the first direct evidence for the apoptotic mode of cell death caused by lycorine in human promyelocytic HL-60 leukemia. To this extent, lycorine slowed down the growth of HL-60 cells (IC 50 1 M) by arresting cell cycle at the G2/M phase [35] . Furthermore, apoptotic morphological changes were indicated by the DNA "ladder" pattern and sub-G1 peak in cell phase distribution [35] At the protein level, increases in caspases-3, -8 and -9, underexpression of Bcl-2 and increase of the Bax:Bcl-2 ratio indicated that both caspase and Bcl-2 family proteins were involved in lycorine-mediated apoptosis in HL-60 cells [35] . Similarly, Zupko et al. (2009) [41] showed that apoptosis induction in HeLa cervical cancer was accompanied by notable changes to the proportion of cells with sub-G1 amounts of DNA. Furthermore, [37] pointed out that apoptosis induction in KM3 myeloma cells is associated with G0/G1 cell cycle arrest. The G0/G1 phase of the cell cycle was also affected by lycorine treatment in K562 cells, but in this case via histone deacetylase (HDAC) inhibition [58] . Liu et al. (2009) [40] then provided evidence to the effect that lycorine manifested its apoptotic effects in K562 leukemia cells via an intrinsic mitochondrial pathway involving rapid turnover of the Mcl-1 protein which occurred prior to caspase activation. Despite the surmounting evidence in favor of the apoptotic pathway, studies by Lamoral-Theys et al. (2009) on the cytotoxic effects of lycorine alkaloids in cells either sensitive or resistant to proapoptotic stimuli suggests the involvement of other factors in cancer cell death [46] . In the same study, Lamoral-Theys et al. (2009) showed that lycorine exerts its in vitro antitumor activity via cytostatic rather than cytotoxic effects [46] .
In summary, despite the wide array of biological properties manifested by the lycorine series of Amaryllidaceae alkaloids, considerable effort has been directed towards their cytotoxic effects, which is understandable given their potent and selective activities in numerous cancer cell lines. Many of such endeavors have been undertaken with the goal of better understanding this potential chemotherapeutic drug target with sub-micromolar activities against some cancers. To this extent, this review is timely in accounting for the cytotoxic effects of 134 different natural and semi-synthetic lycorine alkaloids in 97 cancer and 15 normal cell lines. Although the evidence presented is overwhelmingly in favor of selective cytotoxic effects, the activities against normal cells in some instances cannot be overlooked and should thus guide efforts aimed at maximizing activity. Despite several attempts to pursue the effects of structure on activity it has become clear at the outset that an intact pyrrolo-phenanthridine nucleus, typifying the lycorine skeleton, is the basic structural requirement. However, several leads invoking modification at the various substitutable positions on the lycorine framework should prove insightful in efforts to unravel the active pharmacophore. Although the biological target remains elusive, significant strides have been made towards understanding the molecular mechanism behind these alkaloids, of which their selective apoptosis-inducing activity in cancer cells is most striking. These findings should go some way in facilitating the development of a potent and selective lycorine anticancer drug target for the clinical market.
